Background: GRM5 Biology and Research Relevance

GRM5 (also designated mGluR5) is a member of the Group I metabotropic glutamate receptor family and is a class C G protein-coupled receptor (GPCR). It couples primarily to G_q/11, activating phospholipase C and elevating intracellular IP₃ and diacylglycerol, which in turn mobilize intracellular calcium stores. GRM5 is widely expressed in the central nervous system, including in the striatum, hippocampus, and cortex, and plays critical roles in synaptic plasticity, learning and memory, and pain signaling.

Because of its distribution and function, GRM5 is a validated drug target for neurological and psychiatric disorders including anxiety, depression, Fragile X syndrome, Parkinson's disease, and addiction. Recombinant GRM5 protein enables researchers to perform cell-free binding assays, structure-function studies, and high-throughput compound screening without the complexity of cell-based systems, making it an important reagent in early-stage drug discovery and receptor pharmacology.

Reconstitution and Storage Protocol

Materials required: Sterile deionized water or the manufacturer-recommended reconstitution buffer, low-binding microcentrifuge tubes, and a calibrated micropipette.

Step 1 – Equilibration: Allow the vial to equilibrate to room temperature (18–25 °C) for 5–10 minutes before opening. Do not apply heat to accelerate thawing.

Step 2 – Reconstitution: Briefly centrifuge the vial (1,000 × g, 10 s) to pellet any lyophilized material adhering to the cap or walls. Reconstitute by adding the volume of sterile buffer specified on the product datasheet. Gently pipette up and down to mix; avoid vortexing, which may denature the protein.

Step 3 – Aliquoting: Immediately divide the reconstituted protein into single-use aliquots in low-binding tubes to prevent activity loss from repeated freeze-thaw cycles.

Step 4 – Storage: For short-term use (≤1 week), store at 4 °C. For long-term storage, snap-freeze aliquots in liquid nitrogen and store at -80 °C. Avoid storing at -20 °C with frost-free freezers, as temperature fluctuations accelerate degradation.

Note: Specific reconstitution volumes, buffer composition, and concentration data should be confirmed from the product Certificate of Analysis (CoA) and datasheet provided with each lot.

Quality Verification Before Use

Before committing the recombinant GRM5 protein to downstream assays, confirm protein integrity using the following checks:

• SDS-PAGE: Run a reducing SDS-PAGE gel and compare the apparent molecular weight band against the expected molecular weight stated in the datasheet. A single dominant band at the expected size indicates minimal degradation.
• Western Blot: Confirm identity using an anti-GRM5 antibody or an anti-tag antibody if the protein carries an affinity tag (e.g., His-tag or GST-tag).
• Protein Concentration: Measure absorbance at 280 nm (A₂₈₀) using a spectrophotometer or a colorimetric assay (e.g., BCA or Bradford) calibrated against BSA standards. Cross-reference with the CoA-reported concentration.
• Endotoxin Level: For cell-based downstream assays, verify that endotoxin levels are below assay-specific thresholds using the LAL assay or equivalent. Elevated endotoxin can confound receptor signaling readouts.
• Functional Activity (optional): Where applicable, a ligand binding assay using a known GRM5 agonist (e.g., DHPG) or antagonist (e.g., MPEP) can confirm functional integrity of the protein.

Functional Application Guidelines

Recombinant Human GRM5 Protein (rp364827) is suitable for a range of biochemical and pharmacological applications. The following guidelines support optimal experimental outcomes:

Ligand Binding Assays: GRM5 protein can be coated onto assay plates or used in solution-phase competitive binding formats. Include positive controls (known mGluR5 ligands) and negative controls (buffer only) in every experiment. Optimize protein concentration empirically to achieve a signal-to-noise ratio suitable for your detection platform (e.g., fluorescence polarization, radioligand displacement, or SPR).

Surface Plasmon Resonance (SPR) / Bio-layer Interferometry (BLI): Capture GRM5 via its affinity tag on the appropriate sensor chip or biosensor surface. Confirm baseline stability before injecting analytes. Use a reference channel with no protein or an irrelevant protein to subtract non-specific binding.

ELISA-based Applications: Coat wells at 1–4 µg/mL in carbonate-bicarbonate coating buffer (pH 9.6) overnight at 4 °C. Block with 1–5% BSA or 5% non-fat dry milk in PBS-T for 1 hour at room temperature. Optimize antibody and protein concentrations for each lot.

Cell-free Transcription/Translation or Protein Interaction Studies: Use GRM5 protein as bait in pull-down assays to characterize protein-protein interactions relevant to receptor signaling complexes.

Working concentrations for all applications should be validated empirically; the above ranges are provided as starting points only.

Troubleshooting Common Issues

Use the following troubleshooting guide to diagnose and resolve frequent problems encountered when working with Recombinant Human GRM5 Protein: